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Evaluation of an AI system for glaucoma detection 
Abstract 
Objectives: ​To evaluate the performance of a ​deep learning based Artificial Intelligence            
(AI) software for detection of glaucoma from stereoscopic optic disc photographs, and to             
compare this performance to the performance of a large cohort of ophthalmologists and             
optometrists. 
Methods: ​A retrospective study evaluating the diagnostic performance of an AI           
software (Pegasus v1.0, Visulytix Ltd., London UK) and comparing it to that of 243              
European ophthalmologists and 208 British optometrists, as determined in previous          
studies, for the detection of glaucomatous optic neuropathy from 94 scanned           
stereoscopic photographic slides scanned into digital format. 
Results: ​Pegasus was able to detect glaucomatous optic neuropathy with an accuracy            
of 83.4% (95% CI: 77.5-89.2). This is comparable to an average ophthalmologist            
accuracy of 80.5% (95% CI: 67.2-93.8) and average optometrist accuracy of 80% (95%             
CI: 67-88) on the same images. In addition, the AI system had an intra-observer              
agreement (Cohen’s Kappa, κ) of 0.74 (95% CI: 0.63-0.85), compared to 0.70 (range:             
-0.13-1.00; 95% CI: 0.67-0.73) and 0.71 (range: 0.08-1.00) for ophthalmologists and           
optometrists, respectively. There was no statistically significant difference between the          
performance of the deep learning system and ophthalmologists or optometrists. ​There           
was no statistically significant difference between the performance of the deep learning            
system and ophthalmologists or optometrists. 
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Conclusion: ​T​he AI syste​m obtained a diagnostic performance and repeatability          
comparable to that of the ophthalmologists and optometrists. We conclude that deep            
learning based AI systems, such as Pegasus, demonstrate significant promise in the            
assisted detection of glaucomatous optic neuropathy. 
Keywords: ​glaucoma, optic disc, artificial intelligence, screening, evaluation 
Introduction 
Primary open-angle glaucoma is a major cause of irreversible blindness, affecting an            
estimated 80 million people globally by the year 2020.​1 A large proportion of these              
patients are thought to reside in lower income countries with limited access to care.​1 It is                
commonly accepted that the early recognition of glaucoma, such as through the            
detection of early structural changes of the optic nerve from fundus images, or by the               
detection of raised intraocular pressure, can lead to prompt treatment and the reduction             
in the burden of sight loss. Whilst primary eye care has taken an increased role in the                 
detection of glaucoma, a number of studies have shown high levels of inter-observer             
variability in the assessment of optic nerve pathology.​2-4 
 
The rising prevalence of glaucoma, in part due to ageing populations, imparts a             
significant burden on already stretched secondary eye care clinics globally. It is            
estimated that the National Health Service (NHS) in the United Kingdom will be required              
to make £20 billion efficiency savings in the coming years.​5,6 Traditional models of care,              
whereby primary eye care providers simply refer patients to specialists, have shown            
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mixed results. In 2010, Lockwood et al. ​showed a positive predictive rate of 0.37 in the                
diagnosis of glaucoma or ocular hypertension in patients referred directly from           
community optometrists.​7 One potential consequence of this is increase in referrals to            
Hospital Eye Services (HES).  
 
In more recent times, direct referrals from optometrists to HES have been replaced by              
the establishment of glaucoma referral refinement schemes as a gold standard to which             
eye care organizations should abide.​8 A number of such schemes exist across the             
United Kingdom, notably in Gloucestershire, Nottingham and Portsmouth. The         
Portsmouth based scheme has been particularly effective in streamlining referrals and           
increasing the positive predictive rate to 0.78 (ref. 9). In doing so, HES permit a cost                
saving by treating and managing the patients with glaucoma who should be there.             
Whilst such systems do reduce the number of false positive referrals entering specialist             
care, the overriding concern is that of scalability. Services are reliant on legacy             
computer systems where data is transferred by electronic mail, and constrained by the             
limited clinical time of specialists. Such systems will not be sustainable in years to come               
given the asynchronous rise in disease prevalence versus the number of available and             
trained eye care professionals.​10  
 
The coming of the Artificial Intelligence (AI) age has the potential to transform current              
models of care, with an emphasis on catalyzing service developments that put patient             
convenience first. Traditionally, devolving care outside of HES has been associated with            
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a perceived reduction in quality. By utilising classification algorithms, such solutions           
have the potential to provide quick, accurate decision support at low cost.  
 
AI systems have recently shown great promise in their ability to detect abnormalities             
from fundus images,​11 breast cancer and melanoma.​12 These systems are all based on             
so-called deep neural networks. These are loosely inspired by biology; they consist of a              
number of connected ‘neurons’, each of which performs simple mathematical operations           
on its inputs and feeds the results into the connected neurons. Deep learning refers to               
artificial neural networks where the neurons are arranged in a layered hierarchy;            
networks with a large number of layers are said to be deep.​13 The layers make it                
possible to learn a representation of the data with increasing levels of abstraction. For              
visual tasks, the first layers of the network learn how to represent images as a collection                
of low-level features such as corners, edges, and blobs. As the levels of abstraction              
increase, the network is able to represent more complex patterns such as blood vessels              
or other larger scale features of a fundus image. Deep learning algorithms are able to               
perform tasks without being explicitly programmed; only the architecture of the neural            
network is defined, and the system learns how to perform tasks based on the raw image                
pixels and the corresponding labels (e.g. a diagnosis of glaucoma or normal) for the              
image. Typically, these systems are trained on thousands of examples. 
 
In a previous study by Seo et al.,​14 the diagnostic performance of the deep learning               
system (Pegasus v1.0, Visulytix Ltd., London UK) was evaluated and compared to the             
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consensus opinion of two glaucoma specialists. However, the images used were fairly            
representative of the type of images that the deep learning system was trained on              
during development, namely they were monoscopic digital fundus photographs with a           
circular 30 degrees Field of View (FoV). In this study, we further test the generalisation               
ability of the deep learning system by evaluating it on stereoscopic 15 degrees FoV              
photographic slides captured in 2003 and scanned into digital format. These types of             
images were not used in the development of the system. In addition, the performance of               
the algorithm is compared, retrospectively, to the average performance of a large cohort             
of ophthalmologists and optometrists from previous studies.​2,15 
 
The purpose of this study was to evaluate a deep learning system (Pegasus v1.0,              
Visulytix Ltd., London UK) in the evaluation of stereoscopic optic disc photographs from             
a previously unseen dataset, and compare its performance to that of ophthalmologists            
and optometrists measured in prior studies. Deep learning methods for automated           
diagnosis of glaucoma have previously been developed and validated,​16-18 however the           
performance of a deployed software product has not previously been evaluated and            
compared to the performance of a large number of ophthalmologists and optometrists            
grading the same image data. 
Methods 
In this study, the performance of the Artificial Intelligence (AI) system (Pegasus v1.0,             
Visulytix Ltd., London, United Kingdom) was analysed prospectively, and compared to           
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the average performance of ophthalmologists and optometrists that were determined in           
the previous studies.​2,15  
 
Dataset 
 
The European Optic Disc Assessment Trial (EODAT) was carried out in 2010 and             
evaluated the assessment of stereoscopic optic disc slides by 243 ophthalmologists           
across 11 countries.​2 All ophthalmologists were glaucoma specialists. The stereoscopic          
images were captured by using a 15 degrees Field of View (FoV) Topcon TRC-SS2              
(Topcon corporation, Tokyo, Japan). Patients were selected from a cohort of patients            
and controls who had originally been recruited for a longitudinal glaucoma study at the              
Rotterdam Eye Hospital. The ophthalmologists were asked to view each stereoscopic           
slide through a stereo viewer (Asahi Pentax Stereo Viewer II, Hoya Corporation, Tokyo,             
Japan) and determine a grade; normal or glaucomatous. Importantly, they were given            
unrestricted time to analyse the images. In 2013, a further study was performed in              
conjunction with Moorfields Eye Hospital NHS Foundation Trust, which assessed the           
diagnostic accuracy of 208 optometrists from the United Kingdom.​15  
 
In both studies, the average diagnostic performance and confidence intervals were           
determined. In total there were 94 stereo photographic slides; 40 healthy controls, 48             
with glaucoma, and 6 with ocular hypertension. The healthy controls and ocular            
hypertension examples were considered as non-glaucoma for the analysis of Pegasus           
performance according to the protocols of the previous studies.​2,15 
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All photographs of the glaucoma patients were taken from people that were diagnosed             
with glaucoma by glaucoma specialists based on both the appearance of their optic             
discs and reproducible visual field defects that were thought to match the appearance of              
the optic discs. In addition, other clinical information, such as elevated intraocular            
pressure and family history were taken into account. One eye was randomly selected             
from each patient if both were eligible for inclusion. The appearance of the optic disc               
was not used as a selection criterion. No patients from the original studies had              
significant history of coexisting ocular diseases, histories of intraocular surgery (other           
than cataract surgery or glaucoma surgery), or systemic diseases that could manifest as             
visible features in retinal imagery, such as diabetes mellitus. All patients were selected             
from a cohort of patients that had originally been involved in a longitudinal glaucoma              
study at the Rotterdam Eye Hospital. All patients were of white ethnic origin. 
 
In the original studies, the patient sample size was chosen such that the number of eyes                
was large enough to be able to detect differences, but not too large that it would have                 
caused clinicians to lose focus; if the sample size was too large the grading may have                
been biased from lack of attention. The ophthalmologist and optometrist sample sizes            
from previous studies were chosen to be large enough to capture the range of              
diagnostic performances and determine accurate measurements of the average         
performance of each group. No randomisation was used in the prior studies or the              
current study, apart from the use of random sampling with replacement for estimating             
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confidence intervals for the performance of the AI system. The investigators were not             
blinded to the reference standard when performing the analysis of the AI system. 
 
The Rotterdam Eye Hospital institutional human experimentation committee approved         
the collection and analysis of the data used in this study and previous studies, and               
informed consent was obtained from the subjects after explanation of the nature and             
possible consequences of the study.  
 
AI System Evaluation 
The original stereoscopic slides were scanned into digital format (Fig. 1 and 2), and              
submitted to the AI system. The scanned images had a resolution of 5,600 x 3,600               
pixels, and a file size of approximately 22MB. The diagnostic performance of Pegasus             
was compared to the performance of ophthalmologists and optometrists determined in           
the previous studies.  
 
Pegasus is a cloud-deployed clinical decision support software tool for the evaluation of             
fundus photography and macular Optical Coherence Tomography scans. For fundus          
image evaluation, the system utilises a collection of CNNs, each specialising in a             
different task associated with image evaluation, including: key landmark detection (e.g.           
optic disc, macula and fovea); clinical feature detection (e.g. exudates and           
haemorrhages); and pathology classification and grading (e.g. diabetic retinopathy). In          
aggregate, the development dataset consisted of 136,146 anonymised fundus images          
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collected from multiple private sources that suitably reflects variation in observed           
real-world use cases: patient demographics, types of fundus camera (e.g. manufacturer,           
FoVs ranging from 30 to 50 degrees, resolution, mydriatic and non-mydriatic), and            
acquisition artefacts (e.g. dust and scratches). Images used in algorithm development           
were labelled by between one and five board-certified specialist ophthalmologists from           
the United Kingdom.  
 
The AI system was not trained on any images captured using a 15 degrees FoV or with                 
the Topcon TRC-SS2. Thus, the dataset used in this study provides a good test of the                
generalisation ability of the system to unseen image types. The system is designed to              
generalise to any fundus photograph which contains the optic disc; the system of CNNs              
first extracts the optic disc from the image, standardises its contrast and size, before              
feeding it into another CNN that performs a binary classification into ​normal or ​abnormal              
as well as providing a confidence score. The CNN for abnormality classification is based              
on the ResNet-50 architecture of He et al.​19 The input size to the classification network               
is 224-by-224 pixels. During development of the classification CNN, the network was            
trained from scratch with all parameters randomly initialised at the start of training.             
Further details of the development of the deep learning system, including architecture            
and training data used can be found in Supplementary Material S1. 
 
It is not explicitly enforced that the algorithm detects features of the optic disc that are                
indicative of pathology, instead the algorithm learns to detect important features directly            
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from the raw image pixels after being exposed to a large number of normal and               
pathological optic discs. It is therefore expected that the CNN “looks” for similar features              
to clinicians, such as but not limited to: enlargement of the cup; haemorrhages in the               
direct surrounding of the optic disc; or thinning of the neuroretinal rim. The only              
information presented to the system is the raw image pixels. 
 
The Pegasus AI system also provides visual explanations that help to contextualise the             
AI decision making, such as the measurement of the Vertical Cup-to-Disc Ratio (VCDR)             
and decision heatmaps. The Pegasus decision is intended as an aid to clinicians,             
enabling them to make faster and more accurate decisions by offering a “second             
opinion”. In this study, the accuracy of the VCDR estimate and the visual explanations              
were not assessed, only the accuracy of the decision on whether the patient suffers              
from an optic disc abnormality indicative of glaucomatous optic neuropathy. Pegasus’           
decision took into account both the confidence that the optic disc contained an             
abnormality and the estimated VCDR. 
 
No pre-processing was applied to the stereoscopic slides prior to uploading to the             
Pegasus platform. Unlike the human graders, the AI analysed only one of the images in               
the stereoscopic pair when making a decision, and did not utilise any stereoscopic             
information which may help in glaucoma diagnosis. The image “chosen” by the AI was              
likely to be the image with the best quality view (e.g. best contrast) of the optic disc,                 
since the software extracts the region that it assigns the highest confidence of             
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corresponding to the optic disc prior to disc abnormality and VCDR analysis. The             
“chosen” image from the pair is made apparent by the visual explanation provided by              
the Pegasus AI system. 
 
The performance of Pegasus was assessed in terms of the accuracy, specificity, and             
sensitivity for comparison to the human graders. In addition, the intra-observer           
agreement for Pegasus was estimated by uploading each image of each stereoscopic            
pair individually and computing Cohen’s Kappa (​κ) coefficient between Pegasus’          
decision for left and right images of each pair. Since Pegasus is a deterministic system,               
presenting exactly the same image pixels twice at different times (the protocol used for              
ophthalmologists and optometrists​2,15​) would yield a perfect intra-observer reliability for          
the AI system which is uninformative. From Fig. 2, it is evident that there is some                
difference in appearance between the left and right image of each pair due to, for               
example, variations in illumination and lens glare artefacts. This variation is similar to             
re-acquisitions of monoscopic fundus images for the same patient and is therefore            
suitable for estimating the intra-observer agreement for the AI system. 
 
Confidence intervals, at the 95% significance level, were determined on each of these             
metrics using 1,000 bootstrap replica samples and the percentile method for confidence            
interval estimation. Bootstrap methods are convenient since they do not make           
assumptions on the underlying distribution of the statistic being evaluated. Confidence           
 
 
Evaluation of an AI system for glaucoma detection 
intervals for human graders have been stated, where possible, based on the results             
reported in the original studies.​2,15  
Results 
Including the upload time, each image took on average 7 seconds to be analysed by               
Pegasus. There were no processing failures for any of the images. The authors             
manually reviewed the images and found that 8 images were of insufficient contrast to              
make out all of the features of the optic disc, with 3 images being of particularly poor                 
contrast such that the optic disc was difficult to grade. These were included in the               
performance analysis. 
 
The Pegasus AI system achieved an overall accuracy of 83.7% (95% CI: 77.3-89.1) ​for              
the detection of glaucomatous optic neuropathy (Table 1). This was similar to the             
average accuracy of 243 ophthalmologists and 208 optometrists, as determined in the            
previous studies.​2,15 Using bootstrap sampling to determine 95% confidence intervals on           
the difference between Pegasus and the mean accuracy, sensitivity and specificity for            
optometrists and ophthalmologists, it was determined that there was no statistically           
significant difference between Pegasus and optometrists nor between Pegasus and          
ophthalmologists. 
 
Fig. 3 shows the Receiver Operating Characteristic (ROC) curve for Pegasus with the             
average operating points and confidence intervals plotted for the human graders.           
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Pegasus shows performance that is within the range of both ophthalmologists and            
optometrists. The Area Under the Receiver Operating Characteristic curve (AUROC) for           
the AI system was 87.1% (95% CI: 81.1-92.4). 
 
The intra-observer agreement is given in Table 2, and expressed by using Cohen’s             
Kappa (κ) coefficient. The AI system obtained a Kappa coefficient of 0.74, compared to              
the values of 0.70 and 0.71 for ophthalmologists and optometrists measured in previous             
studies, respectively.  
Discussion 
Automated analysis of the optic nerve head has significant benefits when embedded            
within new clinical workflows. The accurate detection of early optic nerve head changes             
is vital for the detection of early glaucoma. This study is one of the first to evaluate a                  
commercially available AI system to evaluate optic nerve head pathology. Its results            
suggest an overall accuracy similar to that of the average of European ophthalmologists             
(glaucoma specialists) and UK optometrists. The relatively high performance of the           
Pegasus AI system was achieved despite not being able to utilise the stereoscopic             
information in the photographic slides, unlike the human graders who had access to a              
stereoscopic viewer. Furthermore, the Pegasus AI was fast at grading images, taking 7             
seconds to grade each image (including the time taken to upload the 22MB image files).               
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Therefore, it is likely that the AI would be faster than humans at analysing the images,                
which could be helpful in reducing time and expenses in screening programmes.  
 
In addition, the AI system was observed to have good repeatability (κ=0.74) between             
the right and left images of each stereoscopic pair, and was similar to that of human                
graders (​κ≅0.7) from the previous studies.​2,15 In real-life screening environments, the           
repeatability level for humans is likely to be worse due to fatigue and distraction, and               
this could contribute to misdiagnosis. 
 
The Pegasus AI system has also shown robustness to a new type of imagery that it had                 
never explicitly seen before (stereoscopic optic disc slides digitised by scanning),           
demonstrating a good degree of generalisation ability, which has been one of the             
concerns raised when considering the adoption of AI in healthcare.​20 This is in part              
possible because the Pegasus AI system has been designed to be robust to a wide               
range of various fundus imagery by extracting and standardising the optic disc prior to              
anomaly classification.  
 
A strength of this study was that AI was evaluated on imagery that was previously               
unseen by the AI system; this type of imagery was not present in either the               
manufacturer’s training, validation or testing of the AI algorithms. In addition, the image             
quality was typical of clinical practice with approximately 9% of images being difficult to              
grade due to poor image contrast (as assessed by the authors), making it difficult to               
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observe all of the features in the optic disc in those cases. Another strength of this study                 
was the comparison to an accurate measurement of both ophthalmologist and           
optometrist performance levels, with a total of 451 human graders having assessed the             
images for the presence of glaucoma in prior studies.​2,15 Previous studies evaluating the             
performance of deep learning systems for glaucoma diagnosis have not previously           
compared the performance of the deep learning systems to both ophthalmologists           
(glaucoma specialists) and optometrists on the same cohort of patients, and so it has              
not been clear how well they would fit into the clinical workflow.​16-18 The main limitation               
of this study was the relatively small sample size, which was, in part, a compromise for                
the large cohort of human graders. Further studies are required to assess Pegasus             
performance across a larger number of patients and obtain tighter confidence intervals            
on the systems performance. 
 
Deep learning based AI systems, such as Pegasus, are potentially transformative - they             
promise specialist level accuracy for screening and detecting glaucomatous optic          
neuropathy. They are, in addition, agile in the sense they could be potentially tuned for               
bespoke performance, for example, to increase specificity to preset values. This would            
potentially reduce the number of false positives in what is essentially a rare disease.              
Furthermore, through cloud-based deployment, they can potentially provide such         
analysis at very low cost to the healthcare provider - irrespective of geographical             
location. Further investigation, both in terms of clinical and economic analysis, are            
required as such systems are integrated into real world clinical practice. 
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Figures and Tables 
Table 1 Diagnostic performance of ophthalmologists, optometrists and Pegasus AI.          
Confidence intervals were determined at the 95% significance level. Performance          
measures quoted for ophthalmologists and optometrists are the mean and median           
performance, respectively.​2,15  
 Accuracy (%) Specificity (%) Sensitivity (%) 
Mean ophthalmologist​2 80.5  
(95% CI: 67.2-93.8) 
87.4 
(95% CI: 65.8-100) 
74.7  
(95% CI: 53.9-95.5) 
Median optometrist​15 80 
(95% CI: 67-88) 
74 
(95% CI: 62-88) 
92 
(95% CI: 70-100) 
Pegasus AI* 83.7 
(95% CI: 77.3-89.1) 
86.2 
(95% CI: 78.3-93.2)  
80.9 
(95% CI: 71.4-89.6) 
* Confidence intervals were estimated by bootstrap sampling with 1,000 replicas. 
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Table 2 Intra-observer agreement. Agreement measures quoted for ophthalmologists         
and optometrists are the mean and median agreement, respectively. The intra-observer           
agreement for Pegasus was determined by analysing the left and right image of each              
stereoscopic pair separately for all pairs and using bootstrap sampling with 1,000            
replicas to determine 95% confidence intervals. 
 
 Cohen’s Kappa, κ (range) 
Ophthalmologists 0.70  
(range: -0.13-1.00; 95% CI: 0.67-0.73) 
Optometrists 0.71  
(range: 0.08-1.00) 
Pegasus AI 0.74  
(95% CI: 0.63-0.85) 
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Fig. 1 ​Conventional 45 degrees Field of View (FoV) fundus image typical of the dataset               
used to train Pegasus (left), and a scanned stereoscopic optic disc slide from the              
EODAT. 
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Fig. 2 Representative examples of images from the European Optic Disc Assessment            
Trial (EODAT)​2​ that were used in this evaluation.  
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Fig. 3 ​Receiver Operating Characteristic (ROC) curve for Pegasus. The shaded region            
indicates the 95% confidence interval on the Pegasus ROC estimated using bootstrap            
sampling with 1,000 replications. The average performance and 95% confidence          
intervals for ophthalmologists (square), optometrists (diamond), and the Pegasus         
operating point (circle) are plotted. 
 
